We identified CYP11A1 mRNA expression, and thus steroidogenic potential, in a range of cancer types including liver, breast, prostate, lung, kidney, sarcoma, glioma, uterine, cervical, lymphoma, and melanoma (Supplementary Fig. 3f, g)32. This evidence concerns the gene CYP11A1 and cancer.